Top Story
July 22, 2017
A subset of trial participants with type 2 diabetes showed a significant reduction in blood glucose after taking an anti-asthma drug, according to recent study findings.
In the randomized, double blind, placebo-controlled trial, some patients with type 2 diabetes responded to amlexanox (aphthasol, Uluru), an anti-inflammatory and anti-allergic drug that is used to treat asthma. Researchers conducted a molecular analysis of fat cells from the participants who showed a reduction in glucose.